Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study
Aim: To assess the efficacy and safety of hydroxychloroquine with or without azithromycin) in hospitalized adult patients with COVID-19. Methods: We utilized a hospital based prospective data registry. The primary end point was to assess the impact of hydroxychloroquine with or without azithromycin,...
Main Authors: | Markos Kalligeros, Fadi Shehadeh, Eleftheria Atalla, Evangelia K. Mylona, Su Aung, Aakriti Pandita, Jerry Larkin, Martha Sanchez, Francine Touzard-Romo, Amy Brotherton, Rajeev Shah, Cheston B. Cunha, Eleftherios Mylonakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Journal of Global Antimicrobial Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716520301934 |
Similar Items
-
QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
by: Sarah Grewal, et al.
Published: (2020-09-01) -
Hydroxychloroquine and QTc: beyond COVID-19
by: Alberto Castagna, et al.
Published: (2020-10-01) -
Early Alterations of QTc in Patients with COVID-19 Treated with Hydroxychloroquine or Chloroquine in Libreville, Gabon
by: Elsa Ayo Bivigou, et al.
Published: (2022-06-01) -
Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
by: Elizabeth Park, et al.
Published: (2021-10-01) -
Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
by: Anunay Gupta, et al.
Published: (2020-09-01)